Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Sumitomo Pharma America, Inc.
Gilead Sciences
Stanford University
Stanford University
Memorial Sloan Kettering Cancer Center
University of South Florida
INSYS Therapeutics Inc